Koyfin Home > Directory > Health Care > Amphastar Pharma > Debt Issued

Amphastar Pharma Debt Issued Chart (AMPH)

Amphastar Pharma annual/quarterly Debt Issued from 2014 to 2018.
  • Amphastar Pharma Debt Issued for the quarter ending September 09, 2018 was $0m a -12,827.91% decrease of -11m year over year
  • Amphastar Pharma Debt Issued for the last 12 months ending September 09, 2018 was $8m a -127.42% decrease of -11m year over year
  • Amphastar Pharma Annual Debt Issued for 2017 was $19m a 46.28% increase of 9m from 2016
  • Amphastar Pharma Annual Debt Issued for 2016 was $10m a 33.47% increase of 3m from 2015
  • Amphastar Pharma Annual Debt Issued for 2015 was $7m a -659.10% decrease of -45m from 2014
Other Cash Flow Metrics:
  • Amphastar Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $16m a 38.12% increase of 6m year over year
  • Amphastar Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $2m a 389.71% increase of 8m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH Debt Issued Data

09/2018$0m
06/2018$8m
09/2017$8m
06/2017$11m
09/2016$4m
06/2016$3m
03/2016$4m
12/2015$0m
06/2015$0m
03/2015$7m

Annual AMPH Debt Issued Data

2017$19m
2016$10m
2015$7m
2014$52m
2013$66m